No Prescription |
 |
 | ||
|
MICROGEST Prometrium |
|
| ||
No Prescription » Prescription Drugs 11 » MICROGEST Prometrium Progesterone is used as a part of hormone replacement therapy in women who have passed menopause (the change of life) and have not had a hysterectomy (surgery to remove the uterus). Hormone replacement therapy usually includes estrogen which is used to treat symptoms of menopause and reduce the risk of developing certain diseases. However estrogen can also cause abnormal thickening of the lining of the uterus and increase the risk of developing uterine cancer. Progesterone helps to prevent this thickening and decreases the risk of developing uterine cancer. Progesterone is also used to bring on menstruation (period) in women of childbearing age who have had normal periods and then stopped menstruating. Progesterone is in a class of medications called progestins (female hormones). It works as part of hormone replacement therapy by decreasing the amount of estrogen in the uterus. It works to bring on menstruation by replacing the natural progesterone that some women are missing.Progesterone comes as a capsule to take by mouth. It is usually taken once a day in the evening or at bedtime. You will probably take progesterone on a rotating schedule that alternates 10-12 days when you take progesterone with 16-18 days when you do not take the medication. Your doctor will tell you exactly when to take progesterone. To help you remember to take progesterone take it around the same time in the evening. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take progesterone exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Buy MICROGEST Prometrium and other Prescription Drugs 11 products online at Medstore. Buy Online at Medstore - Click Here!
About MICROGEST Prometrium: Product Type: Prescription Drugs 11 MICROGEST ( Prometrium Generic Progesterone-Micronised ) MICROGEST (Prometrium Generic Progesterone-Micronised) Prometrium Generic Progesterone-Micronised 100 mg Softgel Cap 30 (3 x 10) 200 mg Softgel Cap 30 (3 x 10) 400 mg 10 Capsules-Soft Gel 400 mg 5 x 10 Caps-Soft Gel 400mg 10 x 10 SoftCaps Prometrium Generic Progesterone-Micronised MICROGEST
View more Prescription Drugs 11 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
